.jpg?itok=W6nsHDXV)
Company search
Overview
Performance
Portfolio
Dividends
Charges
Gearing
Research
Announcements
Management
Documents
Invest
Data as at: 03/02/2025
In
Objective
To achieve a high level of capital growth by investing worldwide in a diversified portfolio of shares in pharmaceutical and biotechnology companies and related securities in the healthcare sector.
AIC sector
Management group
Company website
Launch date
28/04/1995
March
Domicile
United Kingdom
Fund manager
Sven H. Borho, Trevor M. Polischuk
Dividend frequency
Semi-Annually
Wind-up provisions
Shareholders have approve the continuance of the Company as an investment trust for a further period of five years. Continuation vote at every fifth AGM, the next of which will be in 2029.
| Market Cap (m) | Total assets (m) | Price (last close) | NAV | Discount / premium (%) | Gearing (%) | Dividend yield (%) | Dividend dates | Ongoing charge (%) |
|---|---|---|---|---|---|---|---|---|
| 1,712.89 | 2,077.69 | 340.50 | 386.69 | -11.79 | 3 | 0.82 | Jun, Nov | 0.9 (31/03/2024) |
Scroll
Dividends
Dividends declared in last 12 months
| Ex-dividend date | Payment date | Dividend amount | Special dividend | Financial year |
|---|---|---|---|---|
| 28/11/2024 | 09/01/2025 | 0.700 | No | 2025 |
| 13/06/2024 | 24/07/2024 | 2.100 | No | 2024 |
Scroll
Performance (%)
| Return type | 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|---|
| Worldwide Healthcare Trust | Share price total return | 9.6 | 12.7 | 17.6 | 99.0 |
| Biotechnology & Healthcare AIC sector | Share price total return | 1.1 | -3.8 | -3.7 | 63.1 |
Scroll
Share structure
Number of shares
503,050,654
98,614,546
Traded volumes (number of shares)
| Yesterday | 1 month | 1 year | 5 years | |
|---|---|---|---|---|
| Total | 1,176,759 | 27,855,865 | 304,666,177 | 1,482,339,478 |
| Average | N/A | 1,284,120 | 1,199,100 | 1,175,040 |
Scroll
Traded values (m)
| Yesterday | 1 month | 1 year | 5 years | |
|---|---|---|---|---|
| Total | 4.01 | 90.93 | 1,038.15 | 4,972.04 |
| Average | N/A | 4.20 | 4.09 | 3.94 |
Scroll
Trading details
Top holdings
Data as at : 31/10/2024
| Investment | % of total assets |
|---|---|
| Eli Lilly and Co | 9.8 |
| Boston Scientific Corp | 8.3 |
| Intuitive Surgical Inc | 6.3 |
| Novo Nordisk AS Class B | 6.1 |
| AstraZeneca PLC | 6.0 |
| Stryker Corp | 4.0 |
| Tenet Healthcare Corp | 4.0 |
| Biogen Inc | 3.8 |
| Daiichi Sankyo Co Ltd | 3.6 |
| Merck & Co Inc | 3.4 |
Data provided by Morningstar.
Company documents provided by FE fundinfo.
